Clinical Trials Directory

Trials / Completed

CompletedNCT06907355

CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS

A Double-Blind Randomized Clinical Trial Comparing Levodropropizine, Codeine, Ivy Leaf (Hedera Helix Extract), and Placebo for the Treatment of Acute Cough in Adults With Upper Respiratory Tract Infections in Primary Care

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
196 (actual)
Sponsor
Pontificia Universidad Catolica de Chile · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Upper respiratory tract infections affect millions globally, with cough being one of the most bothersome symptoms. While various treatments exist, their comparative effectiveness remains unclear. This study aims to evaluate and compare three commonly used treatments for acute cough in adults with upper respiratory tract infections: Levodropropizine, Codeine (with Pseudoephedrine and Chlorphenamine), and Ivy Leaf (Hedera Helix Extract). Investigators will conduct a double-blind, parallel-group randomized clinical trial with 184 adults aged 18-65 with acute upper respiratory tract infection and moderate to severe cough. Participants will be randomized to receive Levodropropizine, Codeine + Pseudoephedrine + Chlorphenamine, Ivy Leaf, or Placebo three times a day for 4 days. The primary outcome is cough severity at 48 hours, measured by a cough numerical rating scale. Secondary outcomes include cough severity and duration at 4- and 10-days. This trial will provide high-quality evidence comparing the efficacy of three widely used antitussive medications in primary care settings. The results could help establish evidence-based guidelines for treating acute cough in upper respiratory infections.

Conditions

Interventions

TypeNameDescription
DRUGCodeineCodeine 10mg/5ml + Pseudoephedrine 7.5mg/5ml + Chlorphenamine 0.5mg/5ml: 10ml three times per day during 4 days
DRUGLevodropropizineLevodropropizine 30mg/5ml: 10ml three times per day during 4 days
DRUGIvy Leaves Cough LiquidIvy Leaf (Hedera Helix Extract) 35 mg/5ml: 10ml three times per day during 4 days
DRUGPlaceboVitamins: 10ml three times per day during 4 days

Timeline

Start date
2025-05-13
Primary completion
2025-11-22
Completion
2025-12-01
First posted
2025-04-02
Last updated
2025-12-03

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT06907355. Inclusion in this directory is not an endorsement.